| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CANCER STEM CELLS |
1 Department of Pediatrics, Ann Arbor, Michigan, 48109-0936
2 Oncomed Pharmaceuticals Inc., Redwood City, CA 94063
3 Department of Radiation Oncology, Palo Alto, CA, 94304-1334.
4 Department of Statistics, Ann Arbor, Michigan, 48109-0936
5 Department of Internal Medicine, Ann Arbor, Michigan, 48109-0936
6 Department of Genetics, Palo Alto, CA, 94304-1334.
7 Department of Internal Medicine, Program in Cellular and Molecular Biology, Ann Arbor, Michigan, 48109-0936; Stanford University, Palo Alto, CA and Stanford Institute for Stem Cell Biology and Regenerative Medicine, Palo Alto, CA, 94304-1334.
* To whom correspondence should be addressed. E-mail: mfclarke{at}stanford.edu.
 |
Abstract |
|---|
In human breast cancers, a phenotypically distinct minority population of tumorigenic cancer (TG) cells (sometimes referred to as cancer stem cells) drives tumor growth when transplanted into immunodeficient mice. Our objective was to identify a mouse model of breast cancer stem cells that could have relevance to studying human breast cancer. To do so, we utilized breast tumors of the MMTV-Wnt-1 mice. MMTV-Wnt-1 breast tumors were harvested, dissociated into single cell suspensions, and sorted by flow cytometry on Thy1, CD24, and CD45. Sorted cells were then injected into recipient background FBV/NJ female syngeneic mice. In 6 of 7 tumors examined, Thy1+CD24+ cancer cells, which constituted approximately 1-4% of tumor cells were highly enriched for cells capable of regenerating new tumors when compared to cells of the tumor that did not fit this profile ("Not Thy1+CD24+"). Resultant tumors were of similar phenotypic diversity as the original tumor and behaved in a similar manner when passaged. Microarray analysis comparing Thy1+CD24+ tumor cells to "Not Thy1+CD24+" cells identified a list of differentially expressed genes. Orthologs of these differentially expressed genes predicted survival of human breast cancer patients from two different study groups. These studies suggest that there is a cancer stem cell compartment in the MMTV-Wnt-1 murine breast tumor and that there is a clinical utility of this model for the study of cancer stem cells.
Key Words. Wnt-1, Cancer Stem Cell, Breast Cancer, Murine
This article has been cited by other articles:
|
|
 |
|
  T. Deng, J. C. Liu, K. I. Pritchard, A. Eisen, and E. Zacksenhaus Preferential Killing of Breast Tumor Initiating Cells by N,N-Diethyl-2-[4-(Phenylmethyl)Phenoxy]Ethanamine/Tesmilifene Clin. Cancer Res., January 1, 2009; 15(1): 119 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-L. Asselin-Labat, F. Vaillant, M. Shackleton, T. Bouras, G.J. Lindeman, and J.E. Visvader Delineating the Epithelial Hierarchy in the Mouse Mammary Gland Cold Spring Harb Symp Quant Biol, November 19, 2008; (2008) sqb.2008.73.020v2. [Abstract] [PDF]
|
|
|
|
|
|
J.M Adams, P.N. Kelly, A. Dakic, S. Carotta, S.L. Nutt, and A. Strasser Role of "Cancer Stem Cells" and Cell Survival in Tumor Development and Maintenance Cold Spring Harb Symp Quant Biol, November 6, 2008; (2008) sqb.2008.73.004v1. [Abstract] [PDF]
|
|
|
|
 |
|
 F. Vaillant, M.-L. Asselin-Labat, M. Shackleton, N. C. Forrest, G. J. Lindeman, and J. E. Visvader The Mammary Progenitor Marker CD61/{beta}3 Integrin Identifies Cancer Stem Cells in Mouse Models of Mammary Tumorigenesis Cancer Res., October 1, 2008; 68(19): 7711 - 7717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zhang, F. Behbod, R. L. Atkinson, M. D. Landis, F. Kittrell, D. Edwards, D. Medina, A. Tsimelzon, S. Hilsenbeck, J. E. Green, et al. Identification of Tumor-Initiating Cells in a p53-Null Mouse Model of Breast Cancer Cancer Res., June 15, 2008; 68(12): 4674 - 4682. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
